Bristol Myers, hot off Breyanzi nod, plots new cell therapy factory in Massachusetts
Bristol Myers Squibb, freshly armed with an approval for its CAR-T lymphoma therapy Breyanzi, is making a major cell therapy manufacturing play. The company is...
cell manufacturing
CDMO Vigene plots cell and gene therapy manufacturing expansion, adding 245 new jobs along the way
Close to a year after Maryland-based CDMO Vigene Biosciences cut the ribbon on its headquarters, spiking demand for cell and gene therapy has prompted the...